Authors :
Alina Ivaniuk, MD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA; Tobias Brünger, MS – Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany; Eduardo Pérez-Palma, PhD – Universidad del Desarrollo, Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana. Santiago, Chile; Ludovica Montanucci, PhD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA; Nisha Bhattarai, PhD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA; Katrine Johannesen, MD, PhD – Danish Epilepsy Centre, Filadelfia, Dianalund, Denmark; Jen Pan, PhD – Stanley Center for Psychiatric Research, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Patrick May, PhD – Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Henrike Heyne, MD – Hasso Plattner Institute, Mount Sinai School of Medicine, New York, NY 10029, USA; Ingo Helbig, MD – Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Stephanie Schorge, PhD – Department of Neuroscience, Physiology and Pharmacology, UCL, London WC1E 6BT, UK; Andreas Brunklaus, MD, MRCPCH – The Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK; Rikke Møller, PhD – Danish Epilepsy Centre, Filadelfia, Dianalund, Denmark; Dennis Lal, PhD – Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44106, USA